| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 03/21/2007 | CN1931131A Oil-in-water type nanometer peonol emulsion oral liquid and its prepn process |
| 03/21/2007 | CN1931130A Nanometer emulsion oral liquid of andrographolide and its prepn process |
| 03/21/2007 | CN1931129A Process of preparing biodegradable magnetic medicine carrying polymer microsphere |
| 03/21/2007 | CN1306036C Method for preparing interferon of white blood cells of dogs |
| 03/21/2007 | CN1306033C Production of vaccines |
| 03/21/2007 | CN1306031C Novel natural antibacterial peptide Hippocampusin and its preparation and application |
| 03/21/2007 | CN1305931C Agent for the prevention and treatment of sexually transmitted diseases-1 |
| 03/21/2007 | CN1305904C Human anti-tetanotoxin monoclonal antibody, method for preparation and application |
| 03/21/2007 | CN1305899C Therapeutic peptides |
| 03/21/2007 | CN1305898C Stimulated polypeptide, its coding genes and use of capsule protein HVR1 of hepatitis C virus |
| 03/21/2007 | CN1305889C Substituted 9a-N-[N'-(benzenesulfonyl)carbamoyl-gamma-aminopropyl] and 9a-N-[N'-(beta-cyaneothyl)-N'-(benzenesulfonyl)carbamoyl-gamma-aminopropyl] derivatives of 9-deoxo-9-dihydro-9a-aza-9a-homoerithr |
| 03/21/2007 | CN1305877C Process for preparing cefpiramide sodium |
| 03/21/2007 | CN1305876C One-step method for preparing high-purity cefpoxime proxetil |
| 03/21/2007 | CN1305875C Substituted 2-benzoyl piperazine methyl penem compound, and its preparing method and use |
| 03/21/2007 | CN1305870C Novel flavane derivative and its preparation method and uses |
| 03/21/2007 | CN1305859C Preparation method of methylol hydantoin composite with low content of free formaldehyde |
| 03/21/2007 | CN1305850C Sulfonylamino-derivatives as novel inhibitors of histone deacetylase |
| 03/21/2007 | CN1305527C Vaccine for treating hepatitis B, and its preparation. method |
| 03/21/2007 | CN1305526C Split encephalitis B virus vaccine and method for preparing the same |
| 03/21/2007 | CN1305525C 0157 bacterium gene engineering multivalence subunit vaccine of human and sensitive animals and its preparing method |
| 03/21/2007 | CN1305524C Mycoplasma hyopneumoniae bacterin vaccine |
| 03/21/2007 | CN1305504C Medicine for treating hepatitis |
| 03/21/2007 | CN1305475C Boronic ester and acid compounds, synthesis and uses |
| 03/21/2007 | CN1305472C Medical compsns. against helicobacter pylori |
| 03/21/2007 | CN1305468C Bolengsu compound and its preparation, medicine composition and use |
| 03/21/2007 | CN1305467C Zinc containing compositions for anti-viral use |
| 03/21/2007 | CN1305462C Diffusional implantable delivery system |
| 03/21/2007 | CN1305384C Cheese capable of disinfecting helicobacter pylori |
| 03/20/2007 | US7193081 Process for preparation of cyclic prodrugs of PMEA and PMPA |
| 03/20/2007 | US7193072 Nucleotide sequence coding preferential polypeptide for use in the treatment and prevention of bacterial infections in swine |
| 03/20/2007 | US7193065 activated haptens useful for generating immunogens to HIV protease inhibitors |
| 03/20/2007 | US7192975 Arylimidazole derivatives, preparation and therapeutic used thereof |
| 03/20/2007 | US7192974 Hydroxymethyl substituted dihydroisoxazole derivatives useful as antibiotic agents |
| 03/20/2007 | US7192973 Piperidine derivatives and their use as modulators of chemokine receptor activity (especially CCR5) |
| 03/20/2007 | US7192971 4-Heteroaryl-tetrahydroquinolines and their use as inhibitors of the cholesterin-ester transfer protein |
| 03/20/2007 | US7192953 Antibacterial agents |
| 03/20/2007 | US7192948 Bicyclic heterocycles as HIV integrase inhibitors |
| 03/20/2007 | US7192945 Benzothiazepine derivatives |
| 03/20/2007 | US7192943 Cephem compounds |
| 03/20/2007 | US7192929 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 03/20/2007 | US7192920 Fungicides trans 1-[4-[(2-aminocyclo-hexyl)-amino]N2-[[4''(pentyloxy)[1,1':4', 1''-terphenyl]-4-yl-carbonyl]-L-ornithine]-4-[4(4-hydroxyphenyl)-L-threonine]-5-L-serine-echinocandine B trifluoroacetate; treating infections caused by Candida, Aspergillus, Cryptococcus |
| 03/20/2007 | US7192735 Phosphopantetheinyl transferases and uses thereof |
| 03/20/2007 | US7192715 Diagnostics and therapy of epstein-barr virus in autoimmune disorders |
| 03/20/2007 | US7192607 Formulations for the prevention or the treatment of diseases affecting mucosae or skin, or for pregnancy prevention, and an applicator for the delivery of topical formulations into mucosal cavities |
| 03/20/2007 | US7192602 safe on the skin when in contact with humans, is toxicologically harmless, and is especially suitable for consumption |
| 03/20/2007 | US7192596 Recombinant toxin fragments |
| 03/20/2007 | US7192595 Peptide-based vaccine for influenza |
| 03/20/2007 | US7192582 Human monoclonal antibodies to FC alpha receptor (CD89) |
| 03/20/2007 | US7192575 Antimicrobial composition |
| 03/20/2007 | CA2273985C Novel erythromycin derivatives, method for preparing them and their use as medicine |
| 03/20/2007 | CA2223080C Antigenic group b streptococcus type ii and type iii polysaccharide fragments having a 2,5-anhydro-d-mannose terminal structure and conjugate vaccine thereof |
| 03/20/2007 | CA2206699C 7-alkylidene cephalosporanic acid derivatives and methods of using the same |
| 03/20/2007 | CA2180352C A method of preventing or reducing the risk of infection by bacterial pathogens utilizing simple and conjugated dextrans |
| 03/20/2007 | CA2164798C Novel erythromycin derivatives, process for preparing the same and their use as drugs |
| 03/20/2007 | CA2162154C Use of a transition metal complex for the treatment of septic shock |
| 03/20/2007 | CA2142280C Metal-mediated cross-coupling with ring-metalated porphyrins |
| 03/16/2007 | CA2520178A1 Probiotic compounds derived from lactobacillus casei strain ke01 |
| 03/15/2007 | WO2007030657A1 CRYSTALLINE FORMS OF [1S-(1α, 3α, 4β)]-2- AMINO-1,9-DIHYDRO-9-[4-HYDROXY-3-(HYDROXYMETHYL)-2- METHYLENECYCLOPENTYL]-6H-PURIN-6-ONE |
| 03/15/2007 | WO2007030617A1 Inhibitors of bacterial impdh |
| 03/15/2007 | WO2007030082A1 Use of des-aspartate-angiotensin i |
| 03/15/2007 | WO2007030023A1 A medical composition for treating wounds |
| 03/15/2007 | WO2007029689A1 Method for activation treatment of antigen-presenting cell |
| 03/15/2007 | WO2007029076A1 Isoindole derivatives as antimicrobial agents |
| 03/15/2007 | WO2007029029A2 Tetracyclic indole derivatives as antiviral agents |
| 03/15/2007 | WO2007028823A1 Pcv-2 vaccine |
| 03/15/2007 | WO2007028789A1 Quinazoline derivatives as antiviral agents |
| 03/15/2007 | WO2006133164A3 Anti-trkb monoclonal antibodies and uses thereof |
| 03/15/2007 | WO2006121422A3 Antibodies against clostridium difficile toxins and uses thereof |
| 03/15/2007 | WO2006103429A3 High affinity hiv t cell receptors |
| 03/15/2007 | WO2006097689A3 Antibodies against candida antigens |
| 03/15/2007 | WO2006087563A3 Adjuvant composition comprising aluminium phosphate and 3d-mpl |
| 03/15/2007 | WO2003068169A3 Stabilized synthetic immunogen delivery system |
| 03/15/2007 | US20070060755 Preparation of 1H-imidazo [4,5-C] quinolin-4-amines via 1H-imidazo [4,5-C] quinolin-4-phthalimide intermediates |
| 03/15/2007 | US20070060643 Autoinducer compounds |
| 03/15/2007 | US20070060635 Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents |
| 03/15/2007 | US20070060619 Nicotinamide-based kinase inhibitors |
| 03/15/2007 | US20070060591 Amine substituted (dihydro- or tetrahydro-)quinoline, pyranopyridine, thiapyranopyridine, or naphthyridine derivatives as chemokine receptor modulators; lymphadenopathy associated, human T-cell leukemia/lymphoma, and/or feline immunodeficiency virus infections |
| 03/15/2007 | US20070060572 e.g., 2-(5-fluoro-2-tolyl)-4-(4-aminocarbonylpiperazinylmethyl)-6-[a-aminocarbonyl-2,6-dichlorobenzyl]pyridine; mitogen-activated protein kinase inhibitor; antiinflammatory agent, autoimmune diseases |
| 03/15/2007 | US20070060571 e.g. 4-(5-(4-Chlorophenyl)-3-((nitrooxy)methyl)-3-hydropyrazolyl)benzenesulfonamide and nitric oxide donor (S-nitrosothiols, nitrites, nitrates, N-oxo-N-nitrosamines, sabstrate of nitric oxide synthase); analgesics, antiinflammatory agent, wound healing; gastrointestinal disorders; side effect reduction |
| 03/15/2007 | US20070060562 Novel crystal form of pyrrolidylthiocarbapenem derivative |
| 03/15/2007 | US20070060553 3-Nitrogen-6,7-dioxygen steroids and uses related thereto |
| 03/15/2007 | US20070060541 2' and 3'-nucleoside prodrugs for treating Flaviviridae infections |
| 03/15/2007 | US20070060540 Methods of ameliorating symptoms of herpes infection using immunomodulatory polynucleotide sequences |
| 03/15/2007 | US20070060505 2' and 3'-nucleoside prodrugs for treating Flaviviridae infections |
| 03/15/2007 | US20070060504 2' and 3'-nucleoside prodrugs for treating Flaviviridae infections |
| 03/15/2007 | US20070060503 2' and 3'-nucleoside prodrugs for treating Flaviviridae infections |
| 03/15/2007 | US20070060498 2' and 3'-Prodrugs of 1', 2', 3' or 4'-branched beta -D or beta -L nucleosides provide superior results against flaviviruses and pestiviruses, including hepatitis C virus and viruses that replicate through an RNA dependent RNA reverse transcriptase; administering interferons as second antivirus agent |
| 03/15/2007 | US20070059831 Nucleic acids, polypeptides, compositions, and methods for modulating apoptosis |
| 03/15/2007 | US20070059806 Nucleic acid molecules, polypeptides, antibodies and compositions containing same useful for treating and detecting influenza virus infection |
| 03/15/2007 | US20070059799 Inducing cellular immune responses to hepatitis B virus using peptide and nucleic acid compositions |
| 03/15/2007 | US20070059689 Hybrid glycosylated products and their production and use |
| 03/15/2007 | US20070059684 Method of identifying an antiviral agent |
| 03/15/2007 | US20070059681 Method for production of bioresorable microparticles, microparticles thus obtained and use thereof |
| 03/15/2007 | US20070059389 Preventives or remedies for infection, anti-endotoxin agents, vaccine adjuvants and growth promoters |
| 03/15/2007 | US20070059322 Episome for transfer and expression of heterologous nucleotide sequences in gram positive bacteria; genetic vaccines |
| 03/15/2007 | US20070059317 Potent immunostimulants from microalgae |
| 03/15/2007 | US20070059299 S-adenosyl methionine decarboxylase inhibition for the treatment of a herpes simplex virus infection |
| 03/15/2007 | US20070059261 Antimycotic nail polish formulations comprising substituted 2-aminothiazoles as an active substance |
| 03/15/2007 | CA2621841A1 Tetracyclic indole derivatives as antiviral agents |
| 03/15/2007 | CA2621774A1 A medical composition for treating wounds |